Comparative mitogenic potencies of EGF and TGFα and their dependence on receptor-limitation versus ligand-limitation

Cellular Engineering

Abstract

Transforming growth factor α (TGFα) has been reported to be a more potent agonist when compared to epidermal growth factor (EGF) in several systems while acting via their common receptor, the epidermal growth factor receptor (EGFR). It has been postulated that this increased potency is mediated by the increased recycling of EGFR upon activation by TGFα as against receptor activation by EGF. The authors test this hypothesis by simultaneously measuring mitogenesis and the dynamics of surface receptor number in response to these ligands in NR6 mouse fibroblasts expressing the EGFR. The data demonstrates that increased receptor recycling due to endosomal dissocation of TGFα can indeed realise an increased mitogenic potency relative to EGF under appropriate cellular and experimental conditions (i.e. situations in which the increase in the number of occupied receptors due to receptor sparing by TGFα represents additional mitogenic signalling capacity). However, this difference in receptor trafficking does not uniquely determine the relative potencies of these ligands since TGFα is a less potent mitogen compared to EGF when experimental conditions are dominated by the effects of ligand trafficking on growth factor availability. Thus, the relative potencies of these growth factors are determined in a given context by the relative importance of ligand and receptor trafficking effects which determine the availability of these signalling components. These results are consistent with a suggested model of hormone responsiveness which favours dissociative ligands (such as TGFα) in receptor-limited situations and non-dissociative ligands (such as EGF) in the case of ligand limitation.

Keywords

Transforming growth factor α Epidermal growth factor Mitogenic potency 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson, S. A. (1991): ‘Growth factors and cancer,Science,254, pp. 1146–1153CrossRefGoogle Scholar
  2. Campbell, I. D., Baron, M., Cooke, R. M., Dudgeon, T. J., Fallon, A., Harvey, T. S., andTappin, M. J. (1990): ‘Structure-function relationships in epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-α),Biochem. Pharmacol.,40, pp. 35–40CrossRefGoogle Scholar
  3. Carpenter, G., andWahl, M. I. (1990): ‘The epidermal growth factor family’in Sporn, M. B. andRoberts, A. B. (Eds.): Peptide growth factors and their receptors (Springer-Verlag, Berlin, Heidelberg), pp. 69–171Google Scholar
  4. Chen, P., Gupta, K., andWells, A. (1994): ‘Cell movement elicited by the epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis,J. Cell Biol.,124, pp. 547–555CrossRefGoogle Scholar
  5. Decker, S. J. (1990): ‘Epidermal growth factor and transforming growth factor-alpha induce differential processing of the epidermal growth factor receptor’,Biochem. Biophys. Res. Comm.,166, pp. 615–621CrossRefGoogle Scholar
  6. Ebner, R., andDerynck, R. (1991): ‘Epidermal growth factor and transforming growth factor-α: differential intracellular routing and processing of ligand receptor complexes,Cell Regul.,2, pp. 599–612Google Scholar
  7. French, A. R., Sudlow, G. P., Wiley, H. S. andLauffenburger, D. A. (1994): ‘Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions’,J. Biol. Chem.,269, pp. 15749–15755Google Scholar
  8. French, A. R., Tadaki, D. K., Niyogi, S. K. andLauffenburger, D. A. (1995): ‘Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction’,J. Biol. Chem.,270, pp. 4334–4340CrossRefGoogle Scholar
  9. Herbst, J. J., Opresko, L. K., Walsh, B. J., Lauffenburger, D. A. andWiley, H. S. (1994): ‘Regulation of postendocytic trafficking of the epidermal growth factor through endosomoal retention’,J. Biol. Chem.,269, pp. 12865–12873Google Scholar
  10. Korc, M. andFinman, J. E. (1989): ‘Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-α,J. Biol. Chem.,264, pp. 14990–14999Google Scholar
  11. Kurten, R. C., Cadena, D. L. andGill, G. N. (1996): ‘Enhanced degradation of EGF receptors by a sorting nexin, SNX1,Science,272, pp. 1008–1010CrossRefGoogle Scholar
  12. Lauffenburger, D. A., Chu, L., French, A., Oehrtman, G., Reddy, C., Wells, A., Niyogi, S. andWiley, H. S. (1996): ‘Engineering dynamics of growth factor and other therapeutic ligands’,Biotech. Bioneng.,52, pp. 61–80CrossRefGoogle Scholar
  13. Lax, I., Johnson, A., Howk, R., Sap, J., Bellot, F., Winkler, M., Ullrich, A., Vennstrom, B., Schlessinger, J. andGivol, D. (1988): ‘Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells and differential binding of EGF and transforming growth factor alpha’,Mol. Cell. Biol.,8, pp. 1970–1978Google Scholar
  14. Massague, J. (1983): ‘Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells,J. Biol. Chem.,258, pp. 13614–13620Google Scholar
  15. Montelione, G. T., Winkler, M. E., Burton, L. E., Rinderknecht, E., Sporn, M. B. andWagner, G. (1989): ‘Sequence specific1H NMR assignments and identification of two antiparallel β-sheets in the solution structure of recombinant hTGF-α’,Proc. Natl. Acad. Sci. USA,86, pp. 1519–1523CrossRefGoogle Scholar
  16. Pruss, R. M. andHerschman, H. R. (1977): ‘Variants of 3T3 cells lacking mitogenic response to epidermal growth factor’,Proc. Natl. Acad. Sci. USA,74, pp. 3918–3921CrossRefGoogle Scholar
  17. Reddy, C. C., Wells, A. andLauffenburger, D. A. (1994): ‘Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect’,Biotechnol. Prog.,10, pp. 377–384CrossRefGoogle Scholar
  18. Reddy, C. C., Wells, A. andLauffenburger, D. A. (1996a): ‘Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor α’,J. Cell. Physiol.,166, pp. 512–522CrossRefGoogle Scholar
  19. Reddy, C. C., Niyogi, S. K., Wells, A., Wiley, H. S. andLauffenburger, D. A. (1996b): ‘Engineering epidermal growth factor for enhanced mitogenic potency’,Nature Biotech.,14, pp. 1696–1699CrossRefGoogle Scholar
  20. Wells, A., Welsh, J. B., Lazar, C. S., Wiley, H. S., Gill, G. N. andRosenfeld, M. G. (1990): ‘Ligand-induced transformation by a non-internalizing epidermal growth factor receptor?Science,247, pp. 962–964CrossRefGoogle Scholar
  21. Wiley, H. S., Herbst, J. J., Walsh, J. B., Lauffenburger, D. A., Rosenfeld, M. G. andGill, G. N. (1991): ‘The role of tyrosine kinase activity in endocytosis, compartmentation and down-regulation of the epidermal growth factor receptor’,J. Biol. Chem.,266, pp. 11083–11094Google Scholar

Copyright information

© IFMBE 1998

Authors and Affiliations

  • C. C. Reddy
    • 1
    • 3
  • A. Wells
    • 2
    • 3
  • D. A. Lauffenburger
    • 4
  1. 1.Department of Chemical EngineeringUniversity of Illinois at Urbana-ChampaignUrbanaUSA
  2. 2.Department of PathologyUniversity of Alabama at BirminghamUSA
  3. 3.Birmingham Veterans Administration Medical CenterBirminghamUSA
  4. 4.Department of Chemical Engineering and Center for Biomedical Engineering, 56-341Massachussetts Institute of TechnologyCambridgeUSA

Personalised recommendations